Candel Therapeutics is a Massachusetts based biotechnology company developing its proprietary immuno-oncology platforms, including its Gene Mediated Cytotoxic Immunotherapy platform and rQNestin34.5 platform, for the treatment of solid tumors.
Company (Alive / Active)
117 Kendrick Street
Massachusetts, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)